Risk of diabetes associated with fatty acids in the de novo lipogenesis pathway is independent of insulin sensitivity and response: the Insulin Resistance Atherosclerosis Study (IRAS)
Objective To examine the associations of fatty acids in the de novo lipogenesis (DNL) pathway, specifically myristic acid (14:0), palmitic acid (16:0), cis-palmitoleic acid (c16:1 n-7), cis-myristoleic acid (c14:1n5), stearic acid (18:0) and cis-oleic acid (c18:1 n-9), with 5-year risk of type 2 dia...
Saved in:
| Main Authors: | Anthony J Hanley, Waqas Qureshi, Ingrid D Santaren, Steven M Watkins, Carlos Lorenzo, Lynne E Wagenknecht |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-05-01
|
| Series: | BMJ Open Diabetes Research & Care |
| Online Access: | https://drc.bmj.com/content/7/1/e000691.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue.
by: Laura L Gathercole, et al.
Published: (2011-01-01) -
Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.
by: Fumiaki Imamura, et al.
Published: (2020-06-01) -
An atypical atherogenic chemokine that promotes advanced atherosclerosis and hepatic lipogenesis
by: Omar El Bounkari, et al.
Published: (2025-03-01) -
Insulin therapy and body weight: benefits of biphasic human insulin analogue NovoMix 30
by: Elena Viktorovna Surkova
Published: (2013-03-01) -
Atherosclerosis and Insulin Resistance: Is There a Link Between Them?
by: Alina Diduța Brie, et al.
Published: (2025-05-01)